Holen Sie sich die Stockscreener-App
16.56
1.13%
-0.19
Schlusskurs vom Vortag:
$16.75
Offen:
$17.38
24-Stunden-Volumen:
8.07M
Relative Volume:
1.39
Marktkapitalisierung:
$2.77B
Einnahmen:
$93.95M
Nettoeinkommen (Verlust:
$-129.87M
KGV:
-18.40
EPS:
-0.9
Netto-Cashflow:
$-202.88M
1W Leistung:
+121.09%
1M Leistung:
+138.10%
6M Leistung:
+130.00%
1J Leistung:
+19.57%
1-Tages-Spanne:
$15.86
$17.77
1-Wochen-Bereich:
$12.72
$21.73
52-Wochen-Spanne:
$5.28
$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
16.56 | 2.80B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-28 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-16 | Eingeleitet | Citigroup | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
B. Riley Securities Maintains Wave Life Sciences (WVE) Buy Recommendation - Nasdaq
WVE: B. Riley Securities Raises Price Target Amid Positive Outlo - GuruFocus
Wave Life Sciences' Robust 2026 Pipeline to Support Outlook, Wedbush Says - marketscreener.com
B. Riley Adjusts Price Target on Wave Life Sciences to $37 From $19, Maintains Buy Rating - marketscreener.com
WVE Stock Receives Analyst Rating Update from Wedbush | WVE Stoc - GuruFocus
Wedbush raises WAVE Life Sciences stock price target to $33 on obesity data - Investing.com India
Wave Life Sciences (WVE) Sees Price Target Boost to $33 by Wedbu - GuruFocus
Wedbush Raises Price Target on Wave Life Sciences to $33 From $20, Adds to Best Ideas List, Keeps Outperform Rating - marketscreener.com
Jefferies reiterates buy rating on WAVE Life Sciences stock amid recent pressure - Investing.com India
Adrian Rawcliffe Sells 42,000 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat
Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets - ts2.tech
Wave Life Sciences prices upsized $350M stock offering - MSN
Wave Life Science prices upsized $350M stock ofeering - MSN
Wave Life Sciences (WVE) Stock Faces Sharp Decline - GuruFocus
Wave Life Sciences (WVE) Stock Experiences Decline - GuruFocus
WVE Shares Dip After Secondary Offering and Market Reaction - timothysykes.com
WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally? - Nasdaq
Wave Life Sciences director Henry sells shares for $1.36 million By Investing.com - Investing.com Canada
Wave Life Sciences (WVE) soars to 6-year high on obesity drug clinical trial - MSN
Corrigan sells Wave Life Sciences (WVE) shares worth $217k By Investing.com - Investing.com Nigeria
Golden Cross Alert: 3 Stocks With Major Upside Potential - Investing.com
Wave Life Sciences (WVE) CFO Moran sells shares worth $4.1 million By Investing.com - Investing.com Canada
Corrigan sells Wave Life Sciences (WVE) shares worth $217k - Investing.com
Tan Aik Na of Wave Life Sciences sells $1.82 million in stock - Investing.com Nigeria
Wave Life Sciences (WVE) CFO Moran sells shares worth $4.1 million - Investing.com India
Wave Life Sciences exec Francis sells $6.4m in shares - Investing.com India
Verdine of Wave Life Sciences sells shares worth $269k - Investing.com India
Wave Life Sciences director Wagner sells $189,000 in shares - Investing.com India
Wave Life Sciences exec Francis sells $6.4m in shares By Investing.com - Investing.com Nigeria
Verdine of Wave Life Sciences sells shares worth $269k By Investing.com - Investing.com UK
Wave Life Sciences director Henry sells shares for $1.36 million - Investing.com India
Wave Life Sciences director Rawcliffe sells $630k in shares - Investing.com
Insider Sell: Mark Corrigan Sells Shares of WAVE Life Sciences L - GuruFocus
Golden Cross Alert: 3 Stocks With Major Upside Potential - MarketBeat
Is It Too Late To Buy WVE Shares? - timothysykes.com
Wave Life Sciences (WVE) Stock Drops Significantly by 9.7% - GuruFocus
Wave Life Sciences stock falls after announcing $350 million public offering - Investing.com
Wave Life Sciences: 200% Rally On 1% Weight Loss Feels Bloated (NASDAQ:WVE) - Seeking Alpha
Wave Life Sciences (WVE) Upsizes Public Offering to Raise $350 M - GuruFocus
Wave Life Sciences (WVE) Announces Upsized $350M Public Offering - GuruFocus
Wave Life Sciences falls after pricing $350 mln stock offering - TradingView
Why Wave Life Sciences Stock Crushed it Again Today - sharewise.com
Wave Life Sciences Prices Upsized $350 Million Public Offering - marketscreener.com
Wave Life Sciences prices public offering at $19 per share By Investing.com - Investing.com Nigeria
WVE Stock Offering Expanded and Priced Under Market Value - GuruFocus
Wave Life Sciences prices public offering at $19 per share - Investing.com
Wave Life Sciences Prices $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - Quiver Quantitative
Wave Life Sciences (Nasdaq: WVE) prices $350M share and pre-funded warrant sale - Stock Titan
Wave Life Sciences prices upsized $350 million offering at a price of $19 per share - marketscreener.com
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times
Wave Life Sciences Prices Upsized $350 Million Offering At A Price of $19 Per Share - TradingView
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Wave Life Sciences Ltd-Aktie (WVE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian | Director |
Dec 08 '25 |
Sale |
15.00 |
42,000 |
630,000 |
12,700 |
| Wagner Heidi L | Director |
Dec 08 '25 |
Option Exercise |
5.97 |
14,000 |
83,580 |
51,930 |
| Wagner Heidi L | Director |
Dec 08 '25 |
Sale |
13.50 |
14,000 |
189,000 |
44,930 |
| HENRY CHRISTIAN O | Director |
Dec 08 '25 |
Option Exercise |
5.07 |
87,000 |
440,790 |
54,700 |
| HENRY CHRISTIAN O | Director |
Dec 08 '25 |
Sale |
14.65 |
93,445 |
1,369,324 |
12,700 |
| Tan Aik Na | Director |
Dec 08 '25 |
Option Exercise |
4.85 |
119,230 |
578,270 |
70,400 |
| Tan Aik Na | Director |
Dec 08 '25 |
Sale |
13.58 |
134,218 |
1,823,158 |
25,400 |
| Verdine Gregory L. | Director |
Dec 08 '25 |
Sale |
13.47 |
20,000 |
269,461 |
275,217 |
| Francis Chris | See Remarks |
Dec 08 '25 |
Option Exercise |
4.78 |
441,031 |
2,107,183 |
147,349 |
| Francis Chris | See Remarks |
Dec 08 '25 |
Sale |
14.57 |
441,031 |
6,427,085 |
25,000 |
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):